Sertaconazole Nitrate

CHEMBL1200725 Phase 4 Zugelassen Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
500.8 g/mol
LogP
Phase
4

Sertaconazole nitrate is the nitrate salt form of sertaconazole, a topical antifungal agent used for tinea pedis and dermatophytoses, including atopic dermatitis-associated fungal infection. See sertaconazole for complete pharmacological details.

Molekularmasse

500,8000 g/mol

TPSA

121,00 Ų

Therapeutische Bereiche

Wirkmechanismus

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mechanismus

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

2D-Struktur

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Clc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1.O=[N+]([O-])O

InChI

InChI=1S/C20H15Cl3N2OS.HNO3/c21-14-4-5-16(18(23)8-14)19(9-25-7-6-24-12-25)26-10-13-11-27-20-15(13)2-1-3-17(20)22;2-1(3)4/h1-8,11-12,19H,9-10H2;(H,2,3,4)

Molecular Formula

C20H16Cl3N3O4S

HBD / HBA

1 / 6

Rotierbare Bindungen

6

Schwere Atome

31

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

Sertaconazole nitrate is the nitrate salt form of sertaconazole, a topical antifungal agent used for tinea pedis and dermatophytoses, including atopic dermatitis-associated fungal infection. See sertaconazole for complete pharmacological details.

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Yes, Sertaconazole Nitrate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200725. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 200103. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.